Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction

This study was undertaken to compare the effects of reteplase and alteplase regimens on hemostasis and fibrinolysis in acute myocardial infarction (AM I). Thrombolytic treatment in patients with AMI is hampered by paradoxical procoagulant effects that favor early reocclusion. In vivo data comparing t his effect and the fibrin specificity of double-bolus reteplase and front-l oaded alteplase regimens are not available. In a prospective, randomized st udy, 50 patients with AMI were either treated with double bolus (10 + 10 U) reteplase or with front-loaded alteplase (up to 100 mg) within 6 hours of symptom onset. Thirty apparently healthy persons served as controls. Molecu lar markers of coagulation and fibrinolysis were serially examined for up t o 5 days. Paradoxical thrombin activation at 3 hours after initiation of th erapy was comparable between reteplase and alteplase. Reteplase (65 +/- 5 U /L) and alteplase (72 +/- 8 U/L) caused significantly elevated kallikrein a ctivity at 3 hours after adminstration (p <0.01 vs controls 30 +/- 1 U/L). Fibrin specificity was less for reteplase (p <0.05) with a decrease in fibr inogen at 3 hours to 122 +/- 27 mg/dl versus 224 +/- 28 mg/dl for alteplase (p <0.01 and p <0.05 vs controls). D-Dimer levels at 3 hours were higher ( p <0.05) after reteplase (5,459 +/- 611 ng/ml) versus alteplase (3,445 +/- 679 ng/ml) (both p <0.01 vs controls 243 +/- 17 ng/ml). Plasmin generation (plasmin-antiplasmin complexes) was significantly (p <0.01) increased at 3 hours with both regimens to 27,079 +/- 3,964 mu g/L (reteplase) and 19,522 +/- 2,381 mu g/L (alteplase). The data from 3 hours after start of thrombol ytic therapy proved less marked fibrin specificity of the reteplase regimen (in vivo) compared with front-loaded alteplase. Both regimens have a moder ate procoagulant effect without differences in activation of the kallikrein system.